KRN engages patients, medical teams, researchers, regulatory experts, industry , patient advocates, and other partners to accelerate research in the rare diseases associated with nephrotic syndrome. Our teams collaborate to improve clinical trials and bring evidence to support patient-provider decision making. Through quality initiatives, KRN strives to facilitate the best care for every patient.